Fibroblast Growth Factor Receptor, extracellular domain, Recombinant Human (FGFR, flg5)

Catalog No : USB-F4305-15G
411.51€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Fibroblast Growth Factor Receptor, extracellular domain, Recombinant Human (FGFR, flg5)
Catalog No USB-F4305-15G
Supplier’s Catalog No F4305-15G
Supplier US Biologicals
Source antigen Recombinant, Sf9
Reactivity
Cross reactivity
Applications
Molecular weight 58
Storage -70°C
Other names
Grade Affinity Purified
Purity Purified by lectin affinity chromatography.
Form Supplied as a lyophilized powder in PBS, 10mM Tris-HCl, pH 7.0
Reactivity life 6 months
Note For reserch purpose only
Purity Purified by lectin affinity chromatography.
Description Fibroblast growth factors (FGFs) produce mitogenic and angiogenic effects in target cells by signaling through the cellular surface tyrosine kinase receptors. There are four members of the FGF receptor family: FGFR-1 (flg), FGFR-2 (bek, KGFR), FGFR-3 and FGFR-4. Each receptor contains an extracellular ligand binding domain, a transmembrane region and a cytoplasmic kinase domain (1). Following ligand binding and dimerization, the receptors are phosphorylated at specific tyrosine residues (2). Seven tyrosine residues in the cytoplasmic tail of FGFR-1 can be phosphorylated: Tyr463, Tyr583, Tyr585, Tyr653, Tyr654, Tyr730 and Tyr766. Tyrosine 653 and 654 are important for catalytic activity of the activated FGFR and are essential for signaling (3). The other phosphorylated tyrosine residues may provide docking sites for downstream signaling components such as Crk and PLCgamma (4,5). Source: Sf9 Biological Activity: The human FGF receptor extracellular domain is able to bind radioiodinated basic FGF. In addition, this receptor is able to inhibit basic FGF-mediated proliferation of adrenocortically capillary endothelial cells. Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute to with sterile dH2O or buffer, aliquot and store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.